Skip to main content
ArticleOPEN ACCESS

PI3K/AKT/mTOR inhibitors for advanced or recurrent endometrial cancer

Cochrane Database of Systematic Reviews
DOI: 10.1002/14651858.CD012160
70Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows: To assess the efficacy and safety of PI3K/AKT/mTOR inhibitor-containing regimens in women with locally advanced, metastatic or recurrent endometrial cancer.

Cite

CITATION STYLE

APA

Martyn, J., Roncolato, F., Willson, M. L., Lindemann, K., & Mileshkin, L. (2016, April 21). PI3K/AKT/mTOR inhibitors for advanced or recurrent endometrial cancer. Cochrane Database of Systematic Reviews. John Wiley and Sons Ltd. https://doi.org/10.1002/14651858.CD012160

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free